| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
5 companies
Bradbury Daniel serves as a Chief Executive Officer at EQ and has filed Form 4s across 5 companies. Across recent SEC filings that breaks down to 0 buys and 465 sells. Those positions are worth an estimated $22.4M at current prices.
Historically, Bradbury Daniel's trades have earned a middling insider score of 69/100 across 84 rated trades. Over a 12-month horizon, 70.2% of those trades were profitable, with an average 12-month return of +16.0%.
The biggest single holding is CORT (~$14.9M) as Director. The recent filings there lean toward selling, a net 140,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 21, 2015 | CORT Corcept Therapeutics Inc | Director | Sell | 20,000 | $5.15 | $103,000.00 | -3.4% | |
| Jun 24, 2015 | CORT Corcept Therapeutics Inc | Director | Sell | 20,000 | $6.75 | $134,900.00 | -3.2% |